ResMed (NYSE:RMD) today announced it has acquired Maribo Medico, a privately-held company specializing in the education, diagnosis, treatment and management of sleep-disordered breathing and respiratory diseases. Maribo Medico is Denmark’s market leader in providing sleep-disordered breathing medical devices and accessories.

“Maribo Medico’s strong team and talented leadership, their market reputation, and their commitment to research and education for sleep and respiratory medicine have helped tens of thousands of people in Denmark who suffer from sleep-disordered breathing and chronic obstructive pulmonary disease,” said Anne Reiser, president of ResMed EMEA-APAC. “Maribo and ResMed together will accelerate growth while improving patient quality-of-life and reducing total healthcare system costs in Denmark. This combination is part of our global goal of improving 20 million lives by 2020.”

Maribo Medico employees, including Chief Executive Officer Mette Toxværd Larsen, will continue on in their current roles.

“We are very happy to join with ResMed to help even more people who suffer from sleep-disordered breathing or chronic respiratory diseases,” said Toxværd Larsen. “We’ve had a strong and fruitful partnership with ResMed for more than 15 years, and now we will leverage their global strength to improve many more lives in Denmark, building our position in respiratory care and digital, tele-monitoring solutions.”

Financial terms of the transaction were not disclosed.